Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$900M |
| 2 |
Cisco
CSCO
|
+$204M |
| 3 |
Amazon
AMZN
|
+$152M |
| 4 |
Johnson & Johnson
JNJ
|
+$150M |
| 5 |
Brookfield Infrastructure
BIPC
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$430M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$305M |
| 3 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$299M |
| 4 |
Merck
MRK
|
+$291M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Aclaris Therapeutics
ACRS
$743M
| $197K | ﹤0.01% |
187,553
-74,180
| -28% | -$226K |
|
|
SNCR
3202
DELISTED
Synchronoss Technologies
SNCR
| $196K | ﹤0.01% |
31,552
+4,452
| +16% | +$21.7K |
|
3203
NCS Multistage Holdings
NCSM
$119M
| $195K | ﹤0.01% |
+11,343
| New | +$165K |
|
3204
GCM Grosvenor
GCMG
$751M
| $191K | ﹤0.01% |
21,332
-34,540
| -62% | -$288K |
|
3205
Pixelworks
PXLW
$37.4M
| $185K | ﹤0.01% |
11,751
-907
| -7% | -$13.2K |
|
3206
Pyxis Oncology
PYXS
$182M
| $183K | ﹤0.01% |
101,810
-51,961
| -34% | -$89K |
|
3207
NetSol Technologies
NTWK
$50.8M
| $181K | ﹤0.01% |
84,378
-9,673
| -10% | -$19.4K |
|
3208
Bionano Genomics
BNGO
$12.2M
| $180K | ﹤0.01% |
1,589
-3,567
| -69% | -$373K |
|
|
THRX
3209
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $179K | ﹤0.01% |
44,145
-2,008
| -4% | -$6.13K |
|
3210
Groupon
GRPN
$1.06B
| $177K | ﹤0.01% |
13,803
| – | – |
|
3211
Humacyte
HUMA
$181M
| $177K | ﹤0.01% |
62,237
| – | – |
|
|
EXTO
3212
DELISTED
Almacenes Exito S.A
EXTO
| $175K | ﹤0.01% |
24,469
-26,239
| -52% | -$176K |
|
3213
Paysign
PAYS
$512M
| $174K | ﹤0.01% |
62,131
-12,736
| -17% | -$27.9K |
|
|
ICAD
3214
DELISTED
iCAD Inc
ICAD
| $173K | ﹤0.01% |
97,860
-15,625
| -14% | -$24.8K |
|
3215
Home Federal Bancorp
HFBL
$70.2M
| $170K | ﹤0.01% |
11,496
| – | – |
|
3216
Grupo Aval
AVAL
$6.11B
| $170K | ﹤0.01% |
69,910
-2,356
| -3% | -$5.38K |
|
|
VTNR
3217
DELISTED
Vertex Energy, Inc
VTNR
| $169K | ﹤0.01% |
49,935
+39,747
| +390% | +$156K |
|
3218
Marchex
MCHX
$78M
| $169K | ﹤0.01% |
124,217
-20,037
| -14% | -$28.1K |
|
|
IMMP
3219
Immutep
IMMP
$56M
| $168K | ﹤0.01% |
70,005
| – | – |
|
3220
Xponential Fitness
XPOF
$273M
| $164K | ﹤0.01% |
12,750
-36,782
| -74% | -$498K |
|
|
SILK
3221
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $164K | ﹤0.01% |
13,384
| – | – |
|
3222
Bioventus
BVS
$893M
| $163K | ﹤0.01% |
30,856
+10,978
| +55% | +$43.4K |
|
3223
Wheels Up
UP
$217M
| $162K | ﹤0.01% |
2,361
-213
| -8% | -$8.24K |
|
3224
Sensus Healthcare
SRTS
$47.6M
| $161K | ﹤0.01% |
68,092
+8,701
| +15% | +$20.4K |
|
|
ME
3225
DELISTED
23andMe Holding Co
ME
| $159K | ﹤0.01% |
8,705
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Dimensional Fund Advisors held 3,516 positions worth $342B, up 12% from $305B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 4.3%. Dimensional Fund Advisors opened 49 new positions and exited 103, leaving the 3,516-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2023 buy was Veralto: 961,231 shares worth $79.1M.
- Dimensional Fund Advisors added most to NVIDIA in Q4 2023, an estimated $900M increase.
- Dimensional Fund Advisors's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $430M.
- Dimensional Fund Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $305M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $342B portfolio in Q4 2023.
- Dimensional Fund Advisors opened 49 new positions and closed 103 in Q4 2023.
- Dimensional Fund Advisors's portfolio value rose 12% quarter-over-quarter to $342B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.